A Fibrin Patch‐Based Enhanced Delivery of Human Embryonic Stem Cell‐Derived Vascular Cell Transplantation in a Porcine Model of Postinfarction Left Ventricular Remodeling

It is unknown how to use human embryonic stem cell (hESC) to effectively treat hearts with postinfarction left ventricular (LV) remodeling. Using a porcine model of postinfarction LV remodeling, this study examined the functional improvement of enhanced delivery of combined transplantation of hESC‐derived endothelial cells (ECs) and hESC‐derived smooth muscle cells (SMCs) with a fibrin three‐dimensional (3D) porous scaffold biomatrix. To facilitate tracking the transplanted cells, the hESCs were genetically modified to stably express green fluorescent protein and luciferase (GFP/Luc). Myocardial infarction (MI) was created by ligating the first diagonal coronary artery for 60 minutes followed by reperfusion. Two million each of GFP/Luc hESC‐derived ECs and SMCs were seeded in the 3D porous biomatrix patch and applied to the region of ischemia/reperfusion for cell group (MI+P+C, n = 6), whereas biomatrix without cell (MI+P, n = 5), or saline only (MI, n = 5) were applied to control group hearts with same coronary artery ligation. Functional outcome (1 and 4 weeks follow‐up) of stem cell transplantation was assessed by cardiac magnetic resonance imaging. The transplantation of hESC‐derived vascular cells resulted in significant LV functional improvement. Significant engraftment of hESC‐derived cells was confirmed by both in vivo and ex vivo bioluminescent imaging. The mechanism underlying the functional beneficial effects of cardiac progenitor transplantation is attributed to the increased neovascularization. These findings demonstrate a promising therapeutic potential of using these hESC‐derived vascular cell types and the mode of patch delivery. STEM CELLS 2011;29:367–375

[1]  S. Keirstead,et al.  Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function. , 2010, Experimental hematology.

[2]  Jianyi(Jay) Zhang,et al.  Autologous stem cell transplantation for myocardial repair. , 2004, American journal of physiology. Heart and circulatory physiology.

[3]  Jianyi(Jay) Zhang,et al.  The host immune response is essential for the beneficial effect of adult stem cells after myocardial ischemia. , 2007, Experimental hematology.

[4]  R. Kloner,et al.  Allogeneic Mesenchymal Stem Cell Transplantation in Postinfarcted Rat Myocardium: Short- and Long-Term Effects , 2005, Circulation.

[5]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[6]  Laura J Suggs,et al.  Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. , 2007, Tissue engineering.

[7]  Rona Shofti,et al.  Electromechanical integration of cardiomyocytes derived from human embryonic stem cells , 2004, Nature Biotechnology.

[8]  J. Hare,et al.  Biomarkers of oxidative stress in heart failure. , 2009, Heart failure clinics.

[9]  Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) , 2002 .

[10]  A. From,et al.  Xenotransplantation of Long‐Term‐Cultured Swine Bone Marrow‐Derived Mesenchymal Stem Cells , 2007, Stem cells.

[11]  Jianyi(Jay) Zhang,et al.  Stem Cells for Myocardial Repair With Use of a Transarterial Catheter , 2009, Circulation.

[12]  J. Ingwall,et al.  Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  L Gepstein,et al.  Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. , 2001, The Journal of clinical investigation.

[14]  B. Black,et al.  Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. , 1998, Annual review of cell and developmental biology.

[15]  Joshua M Hare,et al.  Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Cory Swingen,et al.  Bioenergetic and Functional Consequences of Bone Marrow-Derived Multipotent Progenitor Cell Transplantation in Hearts With Postinfarction Left Ventricular Remodeling , 2007, Circulation.

[17]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.

[18]  A. From,et al.  Bioenergetic and functional consequences of stem cell-based VEGF delivery in pressure-overloaded swine hearts. , 2006, American journal of physiology. Heart and circulatory physiology.

[19]  Hiroshi Sato,et al.  Intracoronary Administration of Cardiac Progenitor Cells Alleviates Left Ventricular Dysfunction in Rats With a 30-Day-Old Infarction , 2010, Circulation.

[20]  B Rosner,et al.  Correction of logistic regression relative risk estimates and confidence intervals for systematic within-person measurement error. , 2006, Statistics in medicine.

[21]  Jianyi(Jay) Zhang,et al.  Long-term functional improvement and gene expression changes after bone marrow-derived multipotent progenitor cell transplantation in myocardial infarction. , 2010, American journal of physiology. Heart and circulatory physiology.

[22]  Jonathan L. Linehan,et al.  Efficient and Stable Transgene Expression in Human Embryonic Stem Cells Using Transposon‐Mediated Gene Transfer , 2007, Stem cells.

[23]  Jianyi(Jay) Zhang,et al.  Relationships between regional myocardial wall stress and bioenergetics in hearts with left ventricular hypertrophy. , 2008, American journal of physiology. Heart and circulatory physiology.

[24]  J. Karp,et al.  Death and Proliferation Time Course of Stem Cells Transplanted in the Myocardium , 2009, Molecular Imaging and Biology.

[25]  R. Moon,et al.  Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. , 2008, Blood.

[26]  A. From,et al.  Profound bioenergetic abnormalities in peri-infarct myocardial regions. , 2006, American journal of physiology. Heart and circulatory physiology.

[27]  Laura Suggs,et al.  A PEGylated fibrin patch for mesenchymal stem cell delivery. , 2006, Tissue engineering.

[28]  A. Neskovic,et al.  Left Ventricular Remodeling After Primary Coronary Angioplasty , 2002 .

[29]  A. Zeiher,et al.  Transcoronary transplantation of progenitor cells after myocardial infarction. , 2006, The New England journal of medicine.

[30]  K Ugurbil,et al.  Functional and bioenergetic consequences of postinfarction left ventricular remodeling in a new porcine model. MRI and 31 P-MRS study. , 1996, Circulation.

[31]  A. From,et al.  The Role of the Sca‐1+/CD31− Cardiac Progenitor Cell Population in Postinfarction Left Ventricular Remodeling , 2006, Stem cells.

[32]  Ge Zhang,et al.  Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix. , 2008, Tissue engineering. Part A.

[33]  A. Neskovic,et al.  Left Ventricular Remodeling After Primary Coronary Angioplasty: Patterns of Left Ventricular Dilation and Long-Term Prognostic Implications , 2002, Circulation.